Matthew B. McNeil - Concepedia

Author

Matthew B. McNeil

University of Otago ORCID

Also Known As

M. McNeil, Matthew B McNeil, Matthew B. McNeil, Matthew McNeil

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Otago Maurice Wilkins Centre University of Auckland Infectious Disease Research Institute University of Cambridge

About

Matthew B. McNeil is an author at University of Otago specializing in microbiology, medicine, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	398
2	Biochemistry	5	5	161
3	Health Sciences	4	4	112
4	Engineering	3	3	275
5	Natural Sciences	3	3	119

Matthew B. McNeil

Publications

992

Citations

H-Index

Page 1

	Year	Citations
Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer Corinna Richter, Ron L. Dy, Rebecca E. McKenzie, Nucleic Acids Research EngineeringMicrobial PathogensGeneticsMolecular BiologyMolecular Genetics	2014	188
The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis Natalie J.E. Waller, Chen‐Yi Cheung, Gregory M. Cook, Nature Communications	2023	67
PigS and PigP Regulate Prodigiosin Biosynthesis in<i>Serratia</i>via Differential Control of Divergent Operons, Which Include Predicted Transporters of Sulfur-Containing Molecules Tamzin Gristwood, Matthew B. McNeil, James S. Clulow, Journal of Bacteriology	2010	64
Utilization of CRISPR Interference To Validate MmpL3 as a Drug Target in <i>Mycobacterium tuberculosis</i> Matthew B. McNeil, Gregory M. Cook Antimicrobial Agents and Chemotherapy	2019	64
SdhE Is a Conserved Protein Required for Flavinylation of Succinate Dehydrogenase in Bacteria Matthew B. McNeil, James S. Clulow, Nabil M. Wilf, Journal of Biological Chemistry Flavoprotein SdhaSuccinate DehydrogenaseBiosynthesisEngineeringProkaryotic System	2012	63
Discovery of a cofactor-independent inhibitor of<i>Mycobacterium tuberculosis</i>InhA Yi Xia, Yasheen Zhou, David S. Carter, Life Science Alliance	2018	44
<i>In Vitro</i> Isolation and Characterization of Oxazolidinone-Resistant Mycobacterium tuberculosis Matthew B. McNeil, Devon Dennison, Catherine Shelton, Antimicrobial Agents and Chemotherapy	2017	43
Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors Matthew B. McNeil, Theresa O’Malley, Devon Dennison, mSphere	2020	39
An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis Kiel Hards, Chen‐Yi Cheung, Natalie J.E. Waller, Communications Biology	2022	39
Mutations in MmpL3 alter membrane potential, hydrophobicity and antibiotic susceptibility in Mycobacterium smegmatis Matthew B. McNeil, Devon Dennison, Tanya Parish Microbiology Pathogenic MicrobiologyMmpl3 FunctionBacteriologyMolecular BiologyAntibiotic Susceptibility	2017	35

Page 1